EATRIS provides access to a vast array of expertise and facilities from over 150 top-tier academic centres across Europe. EATRIS focuses on preclinical and early clinical development of drugs, vaccines and diagnostics. Solutions are provided in the fields of advanced therapy medicinal products (ATMPs), biomarkers, imaging and tracing, small molecules and vaccines.
The wide-ranging services portfolio focuses on supporting early decision-making and de-risking of projects with a focus on safe and efficient progression into clinical development.
Examples include validation and development of in vitro and in vivo biomarkers for patient stratification, molecular imaging tracers for drug development programmes, GMP manufacturing of cellular therapy products, patient-derived xenograft models, and many more highly specialised services.
Advanced Therapy Medicinal Products (ATMP)
Provides state of the art technologies for the critical issues in ATMP development such as specialised GMP facilities, imaging facilities for in vivo animal studies, availability of dedicated/ tailored animal models, clinical expertise and clinical facilities.
